SCHEMBL49098

SCHEMBL49098

Oc1cc2ccccc2n1O

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
DAO P14920 3/20 0.53
KDM4E B2RXH2 2/20 0.40
ALDH1A1 P00352 2/20 0.40
KMT2A Q03164 2/20 0.40
MEN1 O00255 1/20 0.40
MAPT P10636 1/20 0.40
HPGD P15428 1/20 0.40
RECQL P46063 1/20 0.40
MCL1 Q07820 1/20 0.38
TSHR P16473 1/20 0.37
CYP1A2 P05177 1/20 0.36
NOTUM Q6P988 1/20 0.34
LDHA P00338 2/20 0.34
CCR2 P41597 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
SLC22A12 Q96S37 1/20 0.33
MAOA P21397 1/20 0.33
MAOB P27338 1/20 0.33
SLC6A2 P23975 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31064866 1.00 DAO (0.53) DAOKDM4EALDH1A1KMT2AMEN1
SCHEMBL30222224 0.74 DAO (0.41) DAOKDM4EALDH1A1KMT2AMEN1
SCHEMBL11012748 0.74 DAO (0.41) DAOKDM4EALDH1A1KMT2AMEN1
SCHEMBL11347910 0.74 DAO (0.41) DAOKDM4EALDH1A1KMT2AMEN1
SCHEMBL3635550 0.74 DAO (0.60) DAOKDM4EALDH1A1KMT2AMEN1
SCHEMBL3008864 0.74 DAO (0.52) DAOKDM4EALDH1A1KMT2AMEN1
SCHEMBL6382774 0.74 DAO (0.65) DAOKDM4EALDH1A1KMT2AMEN1
SCHEMBL28123905 0.71 ALDH1A1 (0.59) DAOKDM4EALDH1A1KMT2AMEN1
SCHEMBL3285152 0.71 KMT2A (0.60) DAOKDM4EALDH1A1KMT2AHPGD
SCHEMBL5642053 0.70 DAO (0.47) DAOKDM4EALDH1A1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1550 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260144724-A1 Mixture of at least five surfactants (I1) to (I5) WELLA GERMANY GMBH (DE) 2026-05-28 US claimed
WO-2026104266-A1 USE OF A NATURAL OCCURRING POLYPHENOL AS AN OXIDATIVE COUPLER DYE PRECURSOR IN AN OXIDATIVE HAIR COLOURING COMPOSITION WELLA GERMANY GMBH (DE) 2026-05-21 WO claimed
EP-4739272-A1 OXIDATIVE HAIR COLOURING COMPOSITION Wella Germany GmbH (DE) 2026-05-13 EP claimed
EP-4731170-A1 OXIDATIVE HAIR COLOURING COMPOSITION COMPRISING A CHELANT MIXTURE Wella Germany GmbH (DE) 2026-04-29 EP claimed
US-12564545-B2 Hair coloring compositions comprising 2-amino-1-propanol as alkalising agents WELLA GERMANY GMBH (DE) 2026-03-03 US claimed
US-20250057874-A1 SYNTHETIC MELANIN NANOPARTICLES AND USES THEREOF THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2025-02-20 US claimed
WO-2025031867-A1 OXIDATIVE HAIR COLOURING COMPOSITION COMPRISING A CHELANT MIXTURE WELLA GERMANY GMBH (DE) 2025-02-13 WO claimed
CN-119345488-A Multifunctional vascular stent releasing double physiotherapy gases and preparation method thereof 东莞市人民医院 2025-01-24 CN claimed
WO-2025008339-A1 OXIDATIVE HAIR COLOURING COMPOSITION WELLA GERMANY GMBH (DE) 2025-01-09 WO claimed
WO-2024258183-A1 SKIN SOOTHING OR ANTI-INFLAMMATORY COMPOSITION COMPRISING METAL-PHENOLIC COMPLEX AND MELANIN OR PRECURSOR THEREOF 코스맥스 주식회사 2024-12-19 WO claimed
EP-0573205-A2 Acidic post-treatment of hair dyed with dihydroxyindole Bristol-Myers Squibb Company (US) 1993-12-08 EP claimed
WO-1993013745-A1 MINERAL OR ORGANIC PARTICLE BASED PRODUCT COMPRISING AN INDOLINE PRODUCT L'OREAL (FR) 1993-07-22 WO claimed
WO-1993013744-A1 INDOLINE PRODUCTS, METHODS FOR PREPARING SAME, AND USE THEREOF IN COSMETICS L'OREAL (FR) 1993-07-22 WO claimed
EP-0498707-A1 Process of dyeing keratinous fibers with a mono- or di-hydroxyindole and a non-oxidative aromatic carbonyl derivative and dyeing agent L'OREAL (FR) 1992-08-12 EP claimed
US-5053053-A PROCESS FOR DYEING KERATINOUS FIBRES WITH A HYDROXYINDOLE IN COMBINATION WITH A QUINONE DERIVATIVE; AND NOVEL 1,4-BENZOQUINONES L'OREAL (FR) 1991-10-01 US claimed
US-5011500-A Developing with source of iodide ions and hydrogen peroxide, nitrite source and oxidizing agents; multicompartment kit; oxidation system; color- and washfast L'OREAL (FR) 1991-04-30 US claimed
EP-0166183-B1 USE OF HYDROXYINDOLE DERIVATIVES FOR THE MANUFACTURE OF A MEDICAMENT FOR LOWERING THE BLOOD PRESSURE MERCK PATENT GmbH (DE) 1990-10-03 EP claimed
EP-0376776-A2 Process for dyeing keratinous fibres with hydroxyindole associated with quinone and 1,4-benzoquinone L'OREAL (FR) 1990-07-04 EP claimed
EP-0342034-A2 Process for dyeing hair by the sequential treatment with metal ion containing composition and dye composition containing 5,6-dihydroxyindole-2-carboxylic acid Bristol-Myers Squibb Company (US) 1989-11-15 EP claimed
EP-0335477-A2 The use of N-substituted-5,6-dihydroxyindoles as a hair coloring agent Bristol-Myers Squibb Company (US) 1989-10-04 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12564545-B2 Hair coloring compositions comprising 2-amino-1-propanol as alkalising agents PHOSPHO1, ALDH7A1, AASDHPPT DAO 27/4885KDM4E 1524/4885ALDH1A1 173/4885
US-20260144724-A1 Mixture of at least five surfactants (I1) to (I5) DEGS1, SGMS1, FABP4 DAO 4064/4885KDM4E 3739/4885ALDH1A1 3076/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.